Projects per year
Personal profile
Research interests
Pulmonary vascualr disease and right ventricular dysfunction. Currently studying the safety and efficacy of beta-blockers in the treatment of right ventricualr dysfunction due to pulmonary arterial hypertension.
Personal profile
Thenappan Thenappan is an Assisatnt Professor in the Department of Medicine at the University of Minnesota. Minneapolis, MN. He is a memeber of American Heart Association, American Thoracic Society, International Society of Heart and Lung Transplant, Pulmonary Vascualr Research Institute, and Pulmonary Hypertension Association. He has published on pulmonary vascualr disease and right ventricuar dysfunction in high impact factor journals including Circulation, Circulation Heart Failure, Journal of American College of Cardiology, American Journal of Respiratory and Critical Care Medicine, European Respiratory Journal, and Chest.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Research Interest Keywords
- Pulmonary vascualr disease
- Right ventricular dysfunction
- Right heart failure
Fingerprint
The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Pathogenic role of Gut Microbiome in Pulmonary Hypertension
CARDIOVASCULAR MEDICAL RESEARCH AND EDUC
10/1/20 → 9/30/23
Project: Research project
-
Outcomes of Patients Referred for Cardiac Rehabilitation after Left Ventricular Assist Device Implantation
Shaaban, A., Schultz, J., Leonard, J., Martin, C. M., Kamdar, F., Alexy, T., Thenappan, T., Pritzker, M., Shaffer, A., John, R. & Cogswell, R., Mar 1 2023, In: ASAIO Journal. 69, 3, p. 304-308 5 p.Research output: Contribution to journal › Article › peer-review
-
Pulmonary Arterial Hypertension Patients Have a Proinflammatory Gut Microbiome and Altered Circulating Microbial Metabolites
Moutsoglou, D. M., Tatah, J., Prisco, S. Z., Prins, K. W., Staley, C., Lopez, S., Blake, M., Teigen, L., Kazmirczak, F., Weir, E. K., Kabage, A. J., Guan, W., Khoruts, A. & Thenappan, T., Mar 15 2023, In: American journal of respiratory and critical care medicine. 207, 6, p. 740-756 17 p.Research output: Contribution to journal › Article › peer-review
-
Right Ventricular Imaging for Predicting Risk in Pulmonary Arterial Hypertension: The Elephant in the Room
Thenappan, T. & Brittain, E. L., May 2023, In: CHEST. 163, 5, p. 1013-1015 3 p.Research output: Contribution to journal › Editorial › peer-review
-
Anticoagulation in pulmonary arterial hypertension - association with mortality, healthcare utilization, and quality of life: The Pulmonary Hypertension Association Registry (PHAR)
Pulmonary Hypertension Association Registry Investigators, Dec 2022, In: Journal of Heart and Lung Transplantation. 41, 12, p. 1808-1818 11 p.Research output: Contribution to journal › Article › peer-review
-
Association of Right Ventricular Afterload With Atrial Fibrillation Risk in Older Adults: The Atherosclerosis Risk in Communities Study
Parikh, R. R., Norby, F. L., Wang, W., Thenappan, T., Prins, K. W., Van't Hof, J. R., Lutsey, P. L., Solomon, S. D., Shah, A. M. & Chen, L. Y., Oct 2022, In: CHEST. 162, 4, p. 884-893 10 p.Research output: Contribution to journal › Article › peer-review